Shri Ahimsa Naturals debuts on the NSE SME platform with a strong IPO subscription, pricing at Rs 119 per share and a GMP of 16%. The company, which exports to 14 countries, saw non-institutional investors book the issue nearly 63 times.
Why FIIs are dumping bluechips to hunt small & midcaps
Foreign institutional investors are shifting their focus from India’s top blue-chip stocks to a wider array of mid- and small-cap companies. This strategic repositioning is